| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,505 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:12AM |
$1.310 |
$1.530 |
risen by
16.79%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC is progressing through Phase 1a/1b clinical studies for Polycystic Kidney Disease (PKD) and Autosomal Dominant Optic Atrophy (ADOA).
- The company reported enrolment and dosing advancements in its clinical trials, with plans for further studies in Q2 2026.
- PYC's financial position as of March 31, 2026, includes $667 million in cash and a $23 million R&D rebate.
- The company reported $16,666,000 in research and development expenses for the quarter.
- PYC is working on drug candidates for Retinitis Pigmentosa type 11 (RP11) and Phelan-McDermid Syndrome (PMS).
- The Appendix 4C cash flow report outlines a net cash use of $16,262,000 in operating activities for the quarter.
- PYC's financing activities brought in a net $563 million due to equity securities issuance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pivotal Metals Limited (PVT) ORDINARY FULLY PAID |
Materials |
$16 |
Horden Lake Strategy Update
|
28 Apr 2026 9:11AM |
$0.015 |
$0.012 |
fallen by
20%
|
|
PVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Mineral Resource update is in progress to enlarge the existing resource.
- A scoping study is advancing, targeting a large open-pit operation.
- Metallurgical testwork aims to improve recovery into clean concentrates.
- Horden Lake holds a strategic position with jurisdictional advantages in Québec.
- Resource growth potential with under-explored regional opportunities.
- The project is positioned against a backdrop of limited global copper development pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Central Petroleum Limited (CTP) ORDINARY FULLY PAID |
Energy |
$41 |
Quarterly Activities Report & Appendix 5B
|
28 Apr 2026 9:11AM |
$0.078 |
$0.055 |
fallen by
29.49%
|
|
CTP - Price-sensitive ASX Announcement
Full Release
Key Points
- Steady production at Palm Valley and Mereenie fields.
- Approval for two new wells at Palm Valley to increase capacity.
- New multi-year Gas Supply Agreement secured.
- Increased sales revenue due to higher gas prices and volumes.
- Challenges in oil sales due to specification constraints.
- Net cash inflow from operating activities.
- Significant cash outflow for investing activities.
- Increased loan facility for drilling support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$515 |
Weekly NTA 24 April 2026
|
28 Apr 2026 9:10AM |
$1.785 |
$1.865 |
risen by
4.48%
|
|
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 9:10AM |
$0.450 |
$0.460 |
risen by
2.22%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic A$2.4 million investment from ZYBT
- FDA confirmation of a single pivotal trial pathway for Elate Ocular®
- Continued advancement in CMC preparations for Phase 3
- Net operating cash outflow of A$0.792 million
- Closing cash balance of A$2.246 million
- Multiple funding strategies to support Phase 3 program
- Key milestone of starting Phase 3 trial in H2 CY 2026
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neometals Limited (NMT) ORDINARY FULLY PAID |
Materials |
$17 |
Application for quotation of securities - NMT
|
28 Apr 2026 9:10AM |
$0.041 |
$0.020 |
fallen by
51.22%
|
|
| Orthocell Limited (OCC) ORDINARY FULLY PAID |
Health Care |
$195 |
Compelling 90% Success Rate for Remplir in Real World Study
|
28 Apr 2026 9:10AM |
$0.850 |
$0.715 |
fallen by
15.88%
|
|
OCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Remplirâ„¢ demonstrates an overall treatment success rate of 89.7%.
- The study involved 66 patients aged 14 to 82 years.
- Majority of procedures were performed in the upper limb.
- No post-treatment complications reported, indicating high safety and biocompatibility.
- 90.3% of motor nerve repairs resulted in functional muscle recovery.
- 89.4% of nerve decompression procedures showed significant symptom improvement.
- The study supports commercial growth in the U.S. and upcoming European markets.
- Orthocell is focused on expanding Remplir's adoption globally.
- Regulatory approval expected in H2 CY26.
- More than 300 surgeons in Australia and 49 in the U.S. are using Remplir.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| eMetals Limited (EMT) ORDINARY FULLY PAID |
Materials |
$5 |
Mineral Range Tungsten Project, Field Activities Commence
|
28 Apr 2026 9:10AM |
$0.007 |
$0.005 |
fallen by
28.57%
|
|
EMT - Price-sensitive ASX Announcement
Full Release
Key Points
- Field activities commenced at Mineral Range Tungsten Project.
- Focus on high-grade tungsten mineralization.
- Project comprises 109 mineral claims over 2,072 acres.
- Initial work involves geological mapping and rock chip sampling.
- High-grade tungsten results from rock chip samples reported.
- Use of modern exploration techniques including UV scheelite scanning.
- Targeting known mineralized zones around historical mines.
- Project uses contact metasomatic processes as exploration framework.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tambourah Metals Ltd (TMB) ORDINARY FULLY PAID |
Materials |
$7 |
Beatty Park Sth EIS Co-Funding and T1 Drilling
|
28 Apr 2026 9:09AM |
$0.047 |
$0.028 |
fallen by
40.43%
|
|
TMB - Price-sensitive ASX Announcement
Full Release
Key Points
- Tambourah Metals awarded $180,000 EIS co-funding grant.
- Initial T1 aircore drilling shows potential for gold system.
- 75-hole program at Beatty Park Sth returned promising results.
- Planning for additional drilling at T2 anomaly and Baxter’s.
- Program aims to explore extensions of Beatty Park Sth gold target.
- Historical data and geophysical surveys used to refine targets.
- Continued analysis to understand gold mineralisation structures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$619 |
Weekly NTA 24.04.2026
|
28 Apr 2026 9:06AM |
$2.580 |
$2.780 |
risen by
7.75%
|
|
| Mammoth Minerals Limited (M79) ORDINARY FULLY PAID |
Materials |
$20 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 9:05AM |
$0.073 |
$0.035 |
fallen by
52.05%
|
|
M79 - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities report for March 2026
- Appendix 5B cash flow report included
- Details about cash flows from operating, investing, and financing activities
- Net cash used in operating activities amounted to $241,000
- No significant investments or financing activities reported
- Cash and cash equivalents at the end of the period were $12,330,000
- No outstanding loan facilities or financing arrangements reported
- Payments to related parties and associates totaled $121,000
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TerraCom Limited (TER) ORDINARY FULLY PAID |
Energy |
$117 |
Quarterly Activities Report
|
28 Apr 2026 9:05AM |
$0.074 |
$0.064 |
fallen by
13.51%
|
|
TER - Price-sensitive ASX Announcement
Full Release
Key Points
- Quarterly activities report for the period ended 31 March 2026.
- March quarter impacted by adverse weather conditions affecting logistics.
- FY26 guidance maintained at 1.6 Mt despite disruptions.
- Completion of a $60 million entitlement offer to strengthen balance sheet.
- Significant management changes including resignation of key executives.
- Strong recovery forecasted with contracted sales for the June quarter.
- FOB operating costs expected to moderate as conditions improve.
- Partnership progress with Wintime Energy Group Co. Ltd.
- Operations in Australia and South Africa continue with strategic focus on cost control.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,341 |
Update - Notification of buy-back - AFI
|
28 Apr 2026 9:05AM |
$6.650 |
$6.750 |
risen by
1.50%
|
|
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$22 |
Initial Director's Interest Notice - Michael Sistenich
|
28 Apr 2026 9:05AM |
$0.044 |
$0.046 |
risen by
4.55%
|
|
| Dorsavi Ltd (DVL) ORDINARY FULLY PAID |
Health Care |
$42 |
DVL Expands Robotics Strategy into Next-Gen Exoskeletons
|
28 Apr 2026 9:04AM |
$0.035 |
$0.034 |
fallen by
2.86%
|
|
DVL - Price-sensitive ASX Announcement
Full Release
Key Points
- dorsaVi Ltd targets exoskeleton systems as a strategic application.
- The company's technology includes wearable motion sensors and neuromorphic semiconductors.
- Exoskeleton systems provide real-time movement monitoring and adaptive control.
- Projected exoskeleton market to exceed USD 2 billion by 2033.
- Technology applicable to broader robotics, including collaborative and surgical robots.
- Expansion leverages existing sensor intelligence platform and RRAM development.
- Focus on human-robot collaboration space with real-time AI-driven decisions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Recharge Metals Limited (REC) ORDINARY FULLY PAID |
Materials |
$22 |
Recharge Starts Sunset Well Exploration, Appoints CEO
|
28 Apr 2026 9:04AM |
$0.034 |
$0.020 |
fallen by
41.18%
|
|
REC - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration commencing at Sunset Well, Leonora, WA.
- Ground gravity and soil sampling programs underway.
- 30,000m of RC, diamond, and aircore drilling planned.
- Sunset Well hosts 2.87Mt @ 1.0 g/t Au for 94,500oz Au.
- Luke Timmermans appointed Chief Executive Officer.
- Felicity Repacholi promoted to Non-Executive Chair.
- Recharge is well funded with over $6 million in capital.
- Focus on execution and value delivery in new project phase.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Djerriwarrh Investments Limited (DJW) ORDINARY FULLY PAID |
Financials |
$713 |
Update - Notification of buy-back - DJW
|
28 Apr 2026 9:03AM |
$2.860 |
$2.720 |
fallen by
4.90%
|
|
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$22 |
Initial Director's Interest Notice - Dr David Fuller
|
28 Apr 2026 9:03AM |
$0.044 |
$0.046 |
risen by
4.55%
|
|
| WOTSO (WOT) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$91 |
Update - Notification of buy-back - WOT
|
28 Apr 2026 9:03AM |
$0.665 |
$0.565 |
fallen by
15.04%
|
|
| Mt Malcolm Mines NL (M2M) ORDINARY FULLY PAID |
Materials |
$7 |
Cleansing Notice - Section 708AA(2)(f)
|
28 Apr 2026 9:02AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
| New Age Exploration Limited (NAE) ORDINARY FULLY PAID |
Energy |
$9 |
Quarterly Activities and Cashflow Report
|
28 Apr 2026 9:02AM |
$0.003 |
$0.002 |
fallen by
33.33%
|
|
NAE - Price-sensitive ASX Announcement
Full Release
Key Points
- Wagyu Gold Project: High-grade gold confirmed, intrusion-related gold system identified.
- Wallah Silver Project: Acquisition expanded geographic and commodity footprint.
- Lammerlaw Project: Phase 2 RC drilling targeting strike extensions and higher-grade shoots.
- Corporate: Kirby Johnson appointed CEO to lead intensified exploration phase.
- Financials: Cash balance at 31 March 2026 is $2.1 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beetaloo Energy Australia Limited (BTL) ORDINARY FULLY PAID |
Energy |
$392 |
Notice of 2026 Annual General Meeting & Proxy Form
|
28 Apr 2026 9:02AM |
$0.300 |
$0.260 |
fallen by
13.33%
|
|
| Mt Malcolm Mines NL (M2M) ORDINARY FULLY PAID |
Materials |
$7 |
Proposed issue of securities - M2M
|
28 Apr 2026 9:02AM |
$0.011 |
$0.009 |
fallen by
18.18%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$95 |
Update - Notification of buy-back - CAM
|
28 Apr 2026 9:02AM |
$0.695 |
$0.670 |
fallen by
3.60%
|
|
| Kingston Resources Limited (KSN) ORDINARY FULLY PAID |
Materials |
$27 |
Accelerated Copper Production at Mineral Hill
|
28 Apr 2026 9:02AM |
$0.093 |
$0.032 |
fallen by
65.59%
|
|
KSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Accelerated copper production at Mineral Hill.
- First copper concentrate produced a quarter ahead of schedule.
- High-quality concentrate with 20% copper and 88% recovery.
- Successful underground ore mining and plant optimization.
- Strategic focus on multi-commodity production at Mineral Hill.
- Strong copper fundamentals and favorable market outlook.
- Trial enabled copper sales to commence early.
- Objectives included plant optimization and operator training.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.